Correlation Between Intellipharmaceutics and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Intellipharmaceutics and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intellipharmaceutics and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intellipharmaceutics International and Protalix Biotherapeutics, you can compare the effects of market volatilities on Intellipharmaceutics and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intellipharmaceutics with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intellipharmaceutics and Protalix Biotherapeutics.
Diversification Opportunities for Intellipharmaceutics and Protalix Biotherapeutics
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Intellipharmaceutics and Protalix is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Intellipharmaceutics Internati and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Intellipharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intellipharmaceutics International are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Intellipharmaceutics i.e., Intellipharmaceutics and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between Intellipharmaceutics and Protalix Biotherapeutics
If you would invest 128.00 in Protalix Biotherapeutics on September 5, 2024 and sell it today you would earn a total of 35.00 from holding Protalix Biotherapeutics or generate 27.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 4.55% |
| Values | Daily Returns |
Intellipharmaceutics Internati vs. Protalix Biotherapeutics
Performance |
| Timeline |
| Intellipharmaceutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Protalix Biotherapeutics |
Intellipharmaceutics and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Intellipharmaceutics and Protalix Biotherapeutics
The main advantage of trading using opposite Intellipharmaceutics and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intellipharmaceutics position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.The idea behind Intellipharmaceutics International and Protalix Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |